is repatha a glp 1 (evolocumab): Uses, Side Effects, Alternatives & More Repatha (Evolocumab) for High Cholesterol:

As diabetes is a major risk factor for CKD [67], specialized expert groups such as the Kidney Disease: Improving Global Outcomes (KDIGO) team, with the endorsement of both ADA and EASD, recommend that glycemic management for T2D patients with CKD should involve a combination of metformin and a SGLT-2 inhibitor as first-line therapy, with other drugs such as SUs considered only when additional therapies are needed for optimum glycemic control [68]

Its always best to prioritize health and consult your doctor for alternatives that are safer

Be prepared for potential follow-up questions from your provider before a treatment plan is determined

Superior to both semaglutide alone and cagrilintide alone

Black individuals constituted 52.5% of cases and 36.0% of controls, while White participants made up to 31.3% and 20.3% respectively ( Table 1 )

So Whats Wrong With Pharmaceuticals